ஜெயந்தி ஓநாய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெயந்தி ஓநாய். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெயந்தி ஓநாய் Today - Breaking & Trending Today

Chutes & Ladders—Roivant's Ramaswamy pegs CFO Giles for chief executive role


Ralph Brandenberger,
 Ph.D., to senior vice president, technical operations. Brandenberger joined the Nkarta team in 2018 and oversees the company s cell therapy manufacturing operations. 
Tracy Dowling as general counsel starting Jan. 25. Dowling will help manage and advise on corporate governance, business development transactions, license agreements, employment law and more. Most recently, Dowling served as associate general counsel at Spark Therapeutics. 
Bernard Courtieu as CEO. Courtieu previously joined IntegraGen as CEO in 2007. 
Eduardo Bravo,
 OncoDNA s interim CEO since July 2020, will remain a consultant to the company s board.
Melanie Ross as chief financial officer, effective immediately. Ross will also serve on the company s board. Most recently, she was group finance director at GVO-B1; prior to that, Ross ....

United Kingdom , United States , Jayanthi Wolf , Vivek Ramaswamy , Matt Gline , Marc Brown , Steve White , Ronald Marcus , Fraiser Kansteiner , Eli Lilly , Melanie Ross , Philip Vickers , Ralph Brandenberger , Jonae Barnes , Todd Fruchterman , Michael Yang , Diego Viacyte , Eduardo Bravo , Brittany Bradrick , Tracy Dowling , Qasim Rizvi , Sumitomo Dainippon , Bernard Courtieu , Cary Pfeffer , Carla Poulson , Jon Lenn ,

Atea Pharmaceuticals Expands Senior Management Team with Key Additions in Regulatory Affairs and Investor Relations and Corporate Communications


Home / Top News / Atea Pharmaceuticals Expands Senior Management Team with Key Additions in Regulatory Affairs and Investor Relations and Corporate Communications
Atea Pharmaceuticals Expands Senior Management Team with Key Additions in Regulatory Affairs and Investor Relations and Corporate Communications
Senior executives bring proven industry experience to leadership roles in regulatory affairs and communications
BOSTON, Jan. 19, 2021 (GLOBE NEWSWIRE) Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that it has expanded its senior management team with the appointments of Jayanthi Wolf, Ph.D., Senior Vice President of Regulatory Affairs and Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications. ....

United States , Boston University , Carol Guaccero , Jean Pierre Sommadossi , Jayanthi Wolf , Jonae Barnes , Sunovion Pharmaceuticals , Idenix Pharmaceuticals , Regulatory Affairs , World Health Organization , Drug Administration , Susquehanna University , Princeton University , Atea Pharmaceuticals , Corporate Communications , Dainippon Sumitomo Pharma Co , Atea Pharmaceuticals Inc , European Medicines Agency , Suffolk University , Senior Vice President , Investor Relations , Chief Executive Officer , World Health , ஒன்றுபட்டது மாநிலங்களில் , போஸ்டன் பல்கலைக்கழகம் , ஜெயந்தி ஓநாய் ,